BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9715603)

  • 1. Reversal reaction, nerve damage and steroid therapy in three multibacillary HIV positive patients.
    Arunthathi S; Ebenezer L; Kumuda C
    Lepr Rev; 1998 Jun; 69(2):173-7. PubMed ID: 9715603
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapse in leprosy after multidrug therapy and its differential diagnosis with reversal reaction.
    Reddy PK; Cherian A
    Indian J Lepr; 1991; 63(1):61-9. PubMed ID: 1919091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions.
    Dawlah ZM; Cabrera A; Ahern K; Levis WR
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):38-43. PubMed ID: 12120041
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immune reconstitution inflammatory syndrome and HIV leprosy co-infection].
    Manga NM; Poda A; Bazolo N; Sané O; Batista G; Guèye NF; Sow PS; Badiane CI
    Med Mal Infect; 2011 Jul; 41(7):390-1. PubMed ID: 21458936
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India.
    Lockwood DN; Vinayakumar S; Stanley JN; McAdam KP; Colston MJ
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):8-15. PubMed ID: 8326184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent iritis in treated bacillary negative leprosy.
    Thompson K; Job CK
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leprosy in five human immunodeficiency virus-infected patients.
    Moran CA; Nelson AM; Tuur SM; Luengu M; Fonseca L; Meyers WM
    Mod Pathol; 1995 Aug; 8(6):662-4. PubMed ID: 8532702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leprosy reactions. New knowledge.
    Naafs B
    Trop Geogr Med; 1994; 46(2):80-4. PubMed ID: 8079395
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemoimmunotherapy: its relevance in contemporary context.
    Sehgal VN; Jain S
    Int J Dermatol; 1994 Oct; 33(10):753-4. PubMed ID: 8002151
    [No Abstract]   [Full Text] [Related]  

  • 10. Enthesopathy in leprosy.
    Carpintero-Benítez P; Logroño C; Collantes-Estevez E
    J Rheumatol; 1996 Jun; 23(6):1020-1. PubMed ID: 8782134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve damage in leprosy.
    Job CK
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):532-9. PubMed ID: 2545801
    [No Abstract]   [Full Text] [Related]  

  • 12. Ulnar abscess: 4 months after release from control with paucibacillary-multidrug therapy.
    Darius EJ; Selvasekar A; Mani MN; Jesudasan K
    Lepr Rev; 1997 Jun; 68(2):173-4. PubMed ID: 9217358
    [No Abstract]   [Full Text] [Related]  

  • 13. Fulminant hepatic failure in a 15 year old boy with borderline lepromatous leprosy and type 2 reaction.
    Mendiratta V; Malik M; Gurtoo A; Chander R
    Lepr Rev; 2014 Mar; 85(1):54-7. PubMed ID: 24974443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactions in borderline leprosy.
    Ramu G; Desikan KV
    Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leprosy - an overview of clinical features, diagnosis, and treatment.
    Fischer M
    J Dtsch Dermatol Ges; 2017 Aug; 15(8):801-827. PubMed ID: 28763601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculous lymphadenitis and borderline leprosy in a patient with isolated unconjugated hyperbilirubinaemia.
    Magazine R; Chogtu B; Manu MK; Shahul HA
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25385559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A florid case of borderline-lepromatous leprosy.
    Raman J; Fisher D
    Med J Aust; 1988 Dec 5-19; 149(11-12):701-2. PubMed ID: 3200196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of IgG subclasses in active and inactive cases in the disease spectrum of leprosy.
    Beuria MK; Parkash O; Joshi B; Mohanty KK; Katoch K; Sengupta U
    Int Arch Allergy Immunol; 1998 Jan; 115(1):61-6. PubMed ID: 9430497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of mast cells in two basic leprosy groups.
    Aroni K; Kontochristopoulos G; Liossi A; Panteleos D
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):634-5. PubMed ID: 8151199
    [No Abstract]   [Full Text] [Related]  

  • 20. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.